Cannabis stocks aren’t finished in 2020 just yet, continuing to report news as the year winds down.

2020 has been a positive year for the cannabis sector with several regulatory milestones achieved, including in Australia.

Cannabis stocks on the ASX have reflected on the consequent improved sentiment, up 34 per cent in 2020 even taking into account the impact of the COVID-19 induced market crash in the March quarter.
 

Here’s a list of all ASX cannabis stocks and their performance in 2020

Code Company Price %Mth %Yr MktCap
WOA Wide Open Agriculture 0.92 -12 581 $83.7M
DTZ Dotz Nano Ltd 0.24 0 314 $90.3M
IHL Incannex Healthcare 0.15 30 150 $149.8M
LSH Lifespot Health Ltd 0.08 -13 135 $10.8M
NTI Neurotech Intl 0.033 14 106 $19.9M
APH AP Hemp Ltd 0.33 16 83 $19.3M
EVE EVE Investments Ltd 0.009 -10 80 $38.4M
CPH Creso Pharma Ltd 0.205 541 71 $134.0M
ZLD Zelira Therapeutics 0.094 38 69 $106.7M
BDA Bod Australia 0.46 -12 56 $46.0M
CP1 Cannpal Animal 0.17 26 55 $15.4M
SCU Stemcell United Ltd 0.018 13 50 $12.4M
ESE Esense-Lab Ltd 0.018 0 50 $9.2M
BOT Botanix Pharma Ltd 0.125 9 49 $121.6M
IDT IDT Australia Ltd 0.165 -13 27 $40.5M
AGH Althea Group 0.42 -14 18 $105.2M
CAN Cann Group Ltd 0.54 74 15 $133.6M
LV1 Live Verdure Ltd 0.19 0 0 $7.4M
LGP Little Green Pharma 0.53 25 0 $41.4M
ECS ECS Botanics Holding 0.042 62 -7 $17.9M
RNO Rhinomed Ltd 0.17 -8 -13 $44.4M
MMJ MMJ Group Hlds Ltd 0.125 4 -14 $27.6M
AC8 Auscann Grp Hlgs Ltd 0.195 50 -15 $52.3M
MXC Mgc Pharmaceuticals 0.026 24 -16 $41.7M
MDC Medlab Clinical Ltd 0.25 32 -23 $69.9M
EOF Ecofibre Limited 1.92 17 -30 $281.7M
PAL Palla Pharma Ltd 0.77 -4 -30 $96.4M
THC THC Global Grp Ltd 0.25 11 -32 $44.6M
ROO Roots Sustainable 0.02 0 -33 $10.7M
SUD Suda Pharmaceuticals 0.036 -8 -34 $11.1M
CAU Cronos Australia 0.13 60 -40 $6.1M
YPB YPB Group Ltd 0.0025 0 -50 $10.6M
RGI Roto-Gro Intl Ltd 0.058 45 -52 $12.8M
CGB Cann Global Limited 0.0065 30 -54 $35.6M
MRG Murray River Grp 0.009 -10 -60 $19.9M
EXL Elixinol Global 0.195 15 -61 $43.4M
EN1 Engage:Bdr Limited 0.006 -25 -74 $14.2M

 

More orders from Europe

The good news has kept rolling in this morning for a couple of ASX cannabis stocks which are involved in the European market.

One is Cann Group (ASX:CAN) which announced the initial order of its medical cannabis oil had just completed shipment to the UK.

Cann is the exclusive supplier to local company LYPHE and LYPHE will utilise Cann’s products as part of participation in Project Twenty21 – Europe’s largest medicinal cannabis recruitment registry. Project Twenty21 provides access to cannabis but also gathers data on treatment efficacy.

Cann says its products will be available to UK doctors to prescribe from next week.

The other cannabis stock with order news was Bod Australia (ASX:BDA). It’s secured $871,413 in binding purchase orders from Italy of its hemp seed oil-based gel product.

This order is additional to the initial $1 million order Bod received only a month ago from Italy and will be sold by Health & Happiness Group (HKSE:1112) across 4,000 pharmacies across Italy.

Bod CEO Jo Patterson said it was pleasing to see positive momentum in such a short space of time.

“We expect additional purchase orders to continue to grow in size and volume,” she said.

 

Are shares getting high?

Cann Group shares rose by 12 per cent while Bod shares rose by 12 per cent this morning.

Bod is in the top 10 cannabis stocks for 2020 gains, having risen over 50 per cent.

Cann Group meanwhile is in negative territory for 2020 after a massive drop during March’s crash but shares have been gradually rising again since securing debt finance with NAB.

Cann Group (ASX:CAN) and Bod Australia (ASX:BDA) share price chart